Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies

Neurosci Lett. 1988 Dec 5;94(3):349-54. doi: 10.1016/0304-3940(88)90043-2.

Abstract

This study was designed to investigate the toxicity of both MPTP and MPP+ using some simple cell systems, such as PC12 and C6 cultures, as models. Exposure of PC12 cells to 0.5 mM MPTP for 72 h resulted in a 50% cell loss with respect to the control cells, and clorgyline, a MAO-A inhibitor, antagonized this toxic effect. Higher concentrations of MPTP demonstrated only a weak cytostatic effect on C6 cells. Moreover, MPP+ showed a toxic effect which was 100 times more evident than MPTP toxicity in the PC12. We found a single, saturable class of [3H]MPP+ binding sites with a relatively high affinity both in PC12 and C6 cell lines. Moreover, the most susceptible cell line towards the toxic effects of both MPTP and MPP+, i.e. PC12, has the higher number of MPP+ binding sites. Our results suggest that MPTP can be toxic not only via MAO-B, but also via MAO-A activity and we propose PC12 as a model to study the intracellular mechanisms of MPTP and MPP+ toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • 1-Methyl-4-phenylpyridinium
  • Adrenal Gland Neoplasms / metabolism
  • Animals
  • Binding Sites
  • Cell Division / drug effects
  • Cell Line
  • Cell Survival / drug effects
  • Dopamine / physiology*
  • Dose-Response Relationship, Drug
  • Macromolecular Substances
  • Monoamine Oxidase Inhibitors / pharmacology
  • Neurotoxins / toxicity*
  • Pheochromocytoma / metabolism
  • Pyridines / antagonists & inhibitors
  • Pyridines / metabolism
  • Pyridines / toxicity*
  • Pyridinium Compounds / metabolism
  • Pyridinium Compounds / toxicity*
  • Rats
  • Tumor Cells, Cultured / cytology
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism

Substances

  • Macromolecular Substances
  • Monoamine Oxidase Inhibitors
  • Neurotoxins
  • Pyridines
  • Pyridinium Compounds
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • 1-Methyl-4-phenylpyridinium
  • Dopamine